ARCHIVES

FDA developing guidelines for oncology endpoints.

This article is from The Cancer Letter archive.

Vol. 30 No. 19 | May 7, 2004

Download PDF Visit The Full Archive

Related Articles

Clinical trials: ORI Cites Data Manager For Misconduct; Results Not Affects, NCI Says

April 2, 1999

Wistar’s Koprowski; Rivera Is Director

April 12, 1991

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

October 23, 2009

Chabner : Opportunity To Set Own Agenda Reason For Leaving

October 28, 1994

Surgery Without Radiation Found Inadequate for DCIS

December 26, 2003

Revised Guidelines For Core, Exploratory Grants Available

March 5, 1976